| Product Code: ETC13220004 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Continuous Subcutaneous Insulin Infusion Market was valued at USD 4.2 Billion in 2024 and is expected to reach USD 6.5 Billion by 2031, growing at a compound annual growth rate of 8.50% during the forecast period (2025-2031).
The Global Continuous Subcutaneous Insulin Infusion (CSII) Market is witnessing significant growth due to the increasing prevalence of diabetes worldwide, technological advancements in insulin delivery devices, and a growing preference for CSII therapy among diabetic patients to achieve better glycemic control. Key players in the market are focusing on developing user-friendly insulin pumps with advanced features, such as automated insulin delivery systems and connectivity options for remote monitoring. North America and Europe dominate the market due to high awareness about diabetes management and favorable reimbursement policies. However, the Asia-Pacific region is expected to witness the fastest growth, driven by the rising diabetic population, improving healthcare infrastructure, and increasing adoption of advanced insulin delivery systems. The market is characterized by intense competition, with major players including Medtronic, Insulet Corporation, and Tandem Diabetes Care leading the way in innovation and market presence.
The Global Continuous Subcutaneous Insulin Infusion Market is experiencing a rising demand due to the increasing prevalence of diabetes worldwide. Key trends in the market include the development of advanced insulin pump technology offering features like continuous glucose monitoring and automated insulin delivery. Additionally, the market is witnessing a shift towards wearable and discreet insulin pumps, enhancing patient convenience and adherence to treatment. Opportunities in the market lie in the growing adoption of insulin pumps among pediatric and geriatric populations, as well as the expanding application of these devices in the management of type 2 diabetes. Market players are focusing on developing innovative and user-friendly insulin pumps to cater to the evolving needs of diabetic patients, presenting significant growth potential in the continuous subcutaneous insulin infusion market.
The Global Continuous Subcutaneous Insulin Infusion Market faces several challenges including regulatory hurdles, limited reimbursement policies, and high upfront costs associated with insulin pump therapy. Regulatory requirements vary across regions, making it difficult for manufacturers to navigate different approval processes and comply with diverse regulations. Additionally, reimbursement policies for insulin pump therapy may be restrictive in some countries, limiting patient access to this technology. The high initial investment required for insulin pumps can also be a barrier for patients, especially in lower-income regions. Addressing these challenges will be crucial for the continuous subcutaneous insulin infusion market to expand and reach a broader patient population.
The Global Continuous Subcutaneous Insulin Infusion market is primarily driven by the increasing prevalence of diabetes worldwide, growing awareness about the benefits of continuous glucose monitoring and insulin delivery systems, technological advancements in insulin pumps, and the rising adoption of these devices for better diabetes management. Additionally, the convenience, flexibility, and improved glycemic control offered by continuous subcutaneous insulin infusion systems are contributing to their popularity among patients and healthcare providers. The increasing focus on personalized and targeted therapy for diabetes, along with the trend towards minimally invasive treatment options, is further fueling the growth of the market. Overall, the demand for continuous subcutaneous insulin infusion systems is expected to continue to rise due to the increasing diabetic population and the need for more effective and efficient diabetes management solutions.
Government policies related to the Global Continuous Subcutaneous Insulin Infusion Market focus on ensuring safety, efficacy, and accessibility of these medical devices. Regulatory bodies such as the FDA in the US and the EMA in Europe have established guidelines for the approval and monitoring of continuous subcutaneous insulin infusion systems, emphasizing the importance of product quality and patient safety. These policies also aim to promote innovation and competition within the market while safeguarding patient interests and ensuring affordability and availability of these devices. Additionally, reimbursement policies and insurance coverage play a crucial role in facilitating patient access to continuous subcutaneous insulin infusion therapy, with governments working towards expanding coverage and reducing out-of-pocket costs for individuals requiring these treatments.
The Global Continuous Subcutaneous Insulin Infusion Market is poised for steady growth in the coming years, driven by the increasing prevalence of diabetes worldwide and the growing adoption of advanced insulin delivery systems. Technological advancements in continuous glucose monitoring and insulin pump technologies are expected to enhance the efficacy and convenience of insulin therapy, further fueling market expansion. Additionally, the rising focus on personalized and patient-centric healthcare solutions is likely to drive innovation in the continuous subcutaneous insulin infusion market, leading to the development of more integrated and automated systems. With a growing emphasis on improving diabetes management and the quality of life for patients, the market is anticipated to witness sustained growth and innovation in the foreseeable future.
The global continuous subcutaneous insulin infusion market shows varying trends across different regions. In Asia, the market is witnessing rapid growth due to the increasing prevalence of diabetes and improving healthcare infrastructure. North America dominates the market due to high adoption rates of advanced insulin delivery systems and favorable reimbursement policies. In Europe, the market is characterized by the presence of key market players and a growing focus on technological advancements in insulin pumps. The Middle East and Africa region is experiencing steady growth driven by rising awareness about diabetes management and increasing healthcare expenditure. Latin America is showing promising growth potential with expanding healthcare access and rising diabetes prevalence. Overall, the global continuous subcutaneous insulin infusion market is expected to continue expanding across all regions with advancements in technology and increasing diabetes cases driving market growth.
Global Continuous Subcutaneous Insulin Infusion Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Continuous Subcutaneous Insulin Infusion Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 & 2031F |
3.3 Global Continuous Subcutaneous Insulin Infusion Market - Industry Life Cycle |
3.4 Global Continuous Subcutaneous Insulin Infusion Market - Porter's Five Forces |
3.5 Global Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.8 Global Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Global Continuous Subcutaneous Insulin Infusion Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Continuous Subcutaneous Insulin Infusion Market Trends |
6 Global Continuous Subcutaneous Insulin Infusion Market, 2021 - 2031 |
6.1 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Tethered, 2021 - 2031 |
6.1.3 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Patch, 2021 - 2031 |
6.2 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.2.3 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.2.4 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Laboratories, 2021 - 2031 |
6.3 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Type 1 diabetes, 2021 - 2031 |
6.3.3 Global Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Type 2 diabetes, 2021 - 2031 |
7 North America Continuous Subcutaneous Insulin Infusion Market, Overview & Analysis |
7.1 North America Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 - 2031 |
7.2 North America Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5 North America Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
8 Latin America (LATAM) Continuous Subcutaneous Insulin Infusion Market, Overview & Analysis |
8.1 Latin America (LATAM) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By End Use, 2021 - 2031 |
8.5 Latin America (LATAM) Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
9 Asia Continuous Subcutaneous Insulin Infusion Market, Overview & Analysis |
9.1 Asia Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By End Use, 2021 - 2031 |
9.5 Asia Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
10 Africa Continuous Subcutaneous Insulin Infusion Market, Overview & Analysis |
10.1 Africa Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By End Use, 2021 - 2031 |
10.5 Africa Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
11 Europe Continuous Subcutaneous Insulin Infusion Market, Overview & Analysis |
11.1 Europe Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By End Use, 2021 - 2031 |
11.5 Europe Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
12 Middle East Continuous Subcutaneous Insulin Infusion Market, Overview & Analysis |
12.1 Middle East Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By End Use, 2021 - 2031 |
12.5 Middle East Continuous Subcutaneous Insulin Infusion Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
13 Global Continuous Subcutaneous Insulin Infusion Market Key Performance Indicators |
14 Global Continuous Subcutaneous Insulin Infusion Market - Export/Import By Countries Assessment |
15 Global Continuous Subcutaneous Insulin Infusion Market - Opportunity Assessment |
15.1 Global Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By End Use, 2021 & 2031F |
15.4 Global Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
16 Global Continuous Subcutaneous Insulin Infusion Market - Competitive Landscape |
16.1 Global Continuous Subcutaneous Insulin Infusion Market Revenue Share, By Companies, 2024 |
16.2 Global Continuous Subcutaneous Insulin Infusion Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |